Adapting existing diabetes risk scores for an Asian population: a risk score for detecting undiagnosed diabetes in the Mongolian population by Dugee, Otgontuya et al.
 
 
This document has been downloaded from  
TamPub – The Institutional Repository of University of Tampere 
 
 
Publisher's version http://urn.fi/URN:NBN:fi:uta-201510072334  
  
Author(s):  Dugee, Otgontuya; Janchiv, Oyunbileg; Jousilahti, Pekka; Sakhiya, Ariuntuya; Palam, Enkhtuya; Nuorti, Pekka; Peltonen, Markku 
Title:  Adapting existing diabetes risk scores for an Asian population: a risk score for detecting undiagnosed diabetes in the Mongolian population 
Year:  2015 
Journal Title: BMC Public Health 
Vol and 
number:  15 : 938  
Pages:  1-9 
ISSN:  1471-2458 
Discipline:  Internal medicine; Health care science 
School 
/Other Unit:  School of Health Sciences 
Item Type:  Journal Article 
Language:  en 
DOI:  http://dx.doi.org/10.1186/s12889-015-2298-9  
URN:  URN:NBN:fi:uta-201510072334 
URL:  http://www.biomedcentral.com/1471-2458/15/938  
 
 
 
 
 
 
 
 
All material supplied via TamPub is protected by copyright and other intellectual 
property rights, and duplication or sale of all part of any of the repository collections 
is not permitted, except that material may be duplicated by you for your research use 
or educational purposes in electronic or print form. You must obtain permission for 
any other use. Electronic or print copies may not be offered, whether for sale or 
otherwise to anyone who is not an authorized user. 
RESEARCH ARTICLE Open Access
Adapting existing diabetes risk scores for an
Asian population: a risk score for detecting
undiagnosed diabetes in the Mongolian
population
Otgontuya Dugee1*, Oyunbileg Janchiv1, Pekka Jousilahti2, Ariuntuya Sakhiya1, Enkhtuya Palam1,
J. Pekka Nuorti3 and Markku Peltonen2
Abstract
Background: Most of the commonly used diabetes mellitus screening tools and risk scores have been developed
with American or European populations in mind. Their applicability, therefore, to low and middle-income countries
remains unquantified. Simultaneously, low and middle-income countries including Mongolia are currently
witnessing rising diabetes prevalence. This research aims to develop and validate a diabetes risk score for the
screening of undiagnosed type 2 diabetes mellitus in the Mongolian adult population.
Methods: Blood glucose measurements from 1018 Mongolians, as well as information on demography and risk
factors prevalence was drawn from 2009 STEPS data. Existing risk scores were applied, measuring sensitivity using
area under ROC-curves. Logistic regression models were used to identify additional independent predictors for
undiagnosed diabetes. Finally, a new risk score was developed and Hosmer-Lemeshow tests were used to evaluate
the agreement between the observed and predicted prevalence.
Results: The performance of existing risk scores to identify undiagnosed diabetes was moderate; with the area
under ROC curves between 61–64 %. In addition to well-established risk factors, three new independent predictors
for undiagnosed diabetes were identified. Incorporating these into a new risk score, the area under ROC curves
increased to 77 % (95 % CI 71 %–82 %).
Conclusions: Existing European or American diabetes risk tools cannot be adopted in Asian countries without prior
validation in the specific population. With this in mind, a low-cost, reliable screening tool for undiagnosed diabetes was
developed and internally validated for Mongolians. The potential for cost and morbidity savings could be significant.
Keywords: Type 2 diabetes, Risk scores, Undiagnosed, Mongolia, Screening
Background
Type 2 diabetes (T2D) is a common disease, and it’s
prevalence has been increasing around the world [1].
Around half of all individuals with T2D are undiagnosed
[2, 3]. The disease is characterized by a long asymptom-
atic preclinical stage with disturbances in glucose metab-
olism, such as impaired fasting glucose (IFG) and
impaired glucose tolerance (IGT). Further, these stages
are often associated with the metabolic syndrome as well
as other risk factors for vascular diseases, and they are
associated with development of micro- and macrovascu-
lar complications in the course of the disease [4, 5].
Sometimes even before the clinical diagnosis of diabetes
[6]. Thus, undiagnosed diabetes and disturbances in glu-
cose metabolism in general are associated with increased
risk of death, by as much three times [7–9].
Early detection of T2D is likely to be beneficial from
the point of view of the individual, as early management
of the disease, its related comorbidities and their risk
factors might lead to benefits such as reduced morbidities* Correspondence: otgon_phi@hotmail.com
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and improved quality of life [10, 11-13]. These benefits
might in turn translate to benefits to the society at large,
in terms of reduced social and economic burden [14, 15].
Several T2D risk scores have been developed world-
wide in order to improve early detection. These risk
scores have been developed in both the prospective set-
ting to identify people who are at increased risk of devel-
oping diabetes in the future [16–20], as well as in the
cross-sectional setting to identify people with undiag-
nosed diabetes [21–27, 28–30]. However, before adopt-
ing existing risk scores as screening tools in different
populations and in different ethnic groups, their per-
formance should be evaluated and validated in the
local setting [31].
Mongolia is a central Asian country, bordered by the
Russian Federation to the north and the People’s Republic
of China to the south. It had a total population of about
2.9 million in 2010, of which some 62 % lived in the urban
area mainly in capital city Ulaanbaatar whereas the rest re-
sides in the large rural territory [32]. The life-expectancy
at birth was 63.2 years for men and 71.2 years for women
in 2011. In a population-based health survey in 1999, the
total prevalence of type 2 diabetes was around 3 % when
standardized with the global population [33]. Of all per-
sons with diabetes in the survey, approximately two-thirds
were unaware of their condition, and one-half of those
with previously diagnosed diabetes were not treated for
the condition in any way [34, 33].
In this study, we developed and validated a modified risk
score for screening of undiagnosed T2D in the cross-
sectional setting, specifically for the Mongolian population.
Methods
Study population
National representative, cross-sectional survey on the
Prevalence of Noncommunicable Disease Risk Factors
was conducted in Mongolia in 2009 using a WHO
STEPwise approach to chronic disease risk factor sur-
veillance. Details of the study protocol have been pub-
lished elsewhere [35]. A total of 5438 randomly selected
individuals aged 15–64 year-old in both sexes were re-
cruited in the survey. The survey collected information
on the risk factors through questionnaire interview,
physical measurement and laboratory analysis. According
to the study protocol every third person aged 25–64 was
selected randomly for the laboratory analysis part of the
survey. The sub study was completed with 1470 individuals
(out of 1812 individuals assigned) aged 25–64 who had
complete information on capillary fasting glucose.
The present analysis included information of the indi-
viduals (N = 1027) in the age group 35–64 years. The
analysis excluded 4 subjects reported to have taken
medication in the morning of the study. So, the analysis
was conducted in 1023 subjects, however the number
further minimized in 1018 with missing values of essen-
tial predictor variables. Thus, the total sample size in the
present analyses is 627 women and 391 men.
Anthropometric measurements
Body weight, height, and waist circumference were
measured in all survey participants. Body weight was
measured in kilograms with electronic scales “GIMA”,
which is a bioimpedance device capable measuring body
weight, body fat percent, and water, muscle and bone
mass. Body height was measured in centimeters using
“Somatometre-Stanley 04-116” device, which has the
capacity to measure height up to 2 meters with a preci-
sion of a millimeter difference. Body mass index (BMI)
was calculated.
Waist circumference was measured with “GIMA waist
meter”, a non-stretchy tape with precision of one milli-
meter. Waist circumference was measured by placing the
tape around bare abdomen just above upper hip bone.
Measurement of glucose and definition of diabetes
Concentrations of glucose were measured in peripheral
(capillary) blood with dry chemical reagent strips using
Accutrend GCT (Glucose, Cholesterol, Triglycerides)
equipment. The required fasting time was 12 hours.
Individuals with blood glucose levels ≥6.1 mmol/l
who were not already on medication for diabetes
were defined as having undiagnosed type 2 diabetes
(T2D) [36].
Measurement of blood pressure
Blood pressure was measured three times on the right
arm of the survey participant in sitting position using
OMRON Model M5 automatic blood pressure monitor.
Mean of three measurements was taken for analysis of
blood pressure. Hypertension was defined as systolic blood
pressure ≥140 mmHg, or diastolic blood pressure ≥90
mmHg, or on medication for high blood pressure [35].
Assessment of lifestyle factors and medication by
questionnaires
Information on medication, history of elevated glucose,
smoking habits, physical activity and nutrition were
collected with detailed questionnaires, which the study
participants answered in a survey interview conducted
by trained interviewers.
History of elevated glucose was assigned if a partici-
pant’s blood glucose had been measured in the past and
a healthcare worker had informed the participant of an
elevated finding. In addition, those reporting that they
were currently on either insulin therapy or medication
for diabetes, or both were defined as individuals with di-
agnosed, drug-treated diabetes and they were excluded
from the present analyses.
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Individuals were categorized as taking medication for
high blood pressure if they stated that a health care
worker had measured their blood pressure and that they
were informed as having elevated blood pressure and
they had taken medication for high blood pressure
during the past two weeks.
Information about both leisure time physical activity
and employment-related physical activity was collected.
Those who responded that they did vigorous or
moderate-intensity sports, fitness or recreational activ-
ities which resulted in increases in breathing or heart
rate lasting for at least 10 minutes continuously on at
least 5 days per week, were categorized as leisure time
physically active. Similarly, respondents were categorized
as being physically active at work if their employment
involved vigorous or moderate-intensity activities caus-
ing increases in breathing or heart rate lasting for at
least 10 minutes [35]. Sedentary behavior and smoking
status were also assessed through questioning.
Existing risk scores
Two existing diabetes risk scores were applicable to the
Mongolian STEPs-survey data and thus to be validated;
the Finnish Diabetes Risk Score FINDRISC [19], and the
Rotterdam Risk Score [26]. The risk scores have proven
internal and external validity [37] and acquire similar
characteristics of risk factors with the existing survey
participants in Mongolia.
Ethics
Ethical approval for the survey was obtained from the
Medical Ethical Committee in the Ministry of Health,
Mongolia. Participation in the survey was voluntary.
Participants of the survey were informed about the
procedures in the survey and consented. Results of the
laboratory analyses were informed to the respondent at
the field directly.
Statistical methods
Demographics and risk factor levels for individuals with
and without undiagnosed diabetes are presented as
means and standard deviations, or as proportions. Com-
parisons between the groups are done with unpaired
t-tests for continuous variables, and Fisher’s exact test
for proportions. For the existing risk scores, the validation
was ensured using sensitivity analysis based on area under
ROC-curves. This measures the discriminatory ability of
the scores.
Logistic regression models were used to identify add-
itional independent predictors for undiagnosed diabetes.
The final model was reached by fitting a model of all
variables significant in univariate analysis and refitting a
model with only the variables significant in the multi-
variate model. In addition to the area under ROC-
curves, calibration plots with corresponding Hosmer-
Lemeshow tests for goodness of fit were used to evaluate
the agreement between observed and predicted preva-
lences. The coefficients of the final prediction model
were transformed to scores by scaling and rounding the
coefficients so that the totals score points would be 22.
As we did not have an external sample which could be
used for validation of the developed score, an internal
validation utilizing bootstrap sampling was conducted
[38]. From the original study population, 1000 random
samples with replacement were drawn, and the model
development process was repeated in each of them. The
resulting 1000 prediction models from these bootstrap
samples were then evaluated with the original study
sample data regarding discrimination and calibration.
This validation gives an estimate of possible overfitting
in the model development process. All analyses were
conducted with statistical software Stata v.10.1.
Results
Among the 1018 individuals with complete data on all
relevant variables, 59 (5.8 %, 35 men and 24 women)
were identified as having undiagnosed diabetes. In gen-
eral, they had worse risk factor profile as compared to
the individuals without diabetes, with exception for age
(Table 1). Measurements on body weight, waist circum-
ference and blood pressure, as well as factors related to
physical activity, nutrition, medication for hypertension
and history of known elevation in glucose levels were
more common among those with undiagnosed diabetes.
Reflecting the more unfavorable risk factor distribution
among those with undiagnosed diabetes, both of the
existing risk scores, the FINDRISC and the Rotterdam
risk score, were higher among those with undiagnosed
diabetes (Table 1). However, the discriminatory power of
these scores was limited. The areas under the curves
were 61.0 (95 % CI: 54.7-68.3) for the FINDRISC, and
63.9 (95 % CI: 56.4-71.3) for the Rotterdam score.
In univariate logistic regression analyses, most of the
variables presented in Table 1 were statistically signifi-
cantly associated with undiagnosed diabetes (Table 2). In
multivariate logistic regression, sex, waist circumference,
hypertension or medication for high blood pressure, his-
tory of elevated glucose, leisure time physical activity and
sitting time 6 hours or more during day were all inde-
pendently associated with undiagnosed diabetes (Table 2).
The area under ROC curve for this model was 76.1 (95 %
CI 70.1-82.1), indicating marked improvement over the
existing risk scores’ performance.
Categorizing waist circumference into 2 groups
further refined the multivariate prediction model
(≥90 cm, and ≥80 cm for men and women, respectively),
and the parameters were then re-estimated (Table 3). All
the variables in the model were still statistically significant,
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and the discrimination was 76.2 (95 % CI: 70.2-82.2). Fi-
nally, the coefficients of the prediction model were trans-
formed into score points, so that the sum of the scores
would maximally be 22. The discrimination with this
score system was virtually unchanged. Sensitivities and
specificities for the original model with continuous vari-
ables and the final score are presented in Fig. 1 (left panel).
In addition to the discrimination of the prediction
model, also the agreement between the predicted preva-
lences based on the score points, to the actually ob-
served prevalences was good (Fig. 1, right panel). There
were no marked deviations from the identity line be-
tween observed and predicted prevalences, and the
Hosmer-Lemeshow test was non-significant (p = 0.44),
indicating adequate goodness-of-fit. Further, the agree-
ment between predicted and observed risk was equally
good in men and women (Hosmer-Lemeshow test p = 0.83
in men and p = 0.50 in women).
Sensitivities, specificities and predicted values for the
score are presented with different cut-off values in
Table 4. The cut-off point 9 on the score was identified
as mathematically most optimal in terms of sensitivity
and specificity. With this cut-off, 43.4 % of the study
population would have been identified as eligible for fur-
ther diagnostic testing, and 81.4 % of all individuals with
undiagnosed diabetes would have been consequently de-
tected. Increasing the cut-off value decreases the propor-
tion of study population to be included in diagnostic
testing markedly, and correspondingly specificity and
positive predictive values increases. However, this hap-
pens at the cost of a decrease in sensitivity.
The results from the internal validation with bootstrap
samples indicated that the area under ROC curve was re-
duced to 72.1 % when taking into consideration the uncer-
tainty in the model development process, as compared to
the observed 76.3 % in the original sample. Further, the
bias in absolute risk prediction for undiagnosed diabetes
was 1.7 %-units in the highest risk quartile (i.e. it is
expected that in external samples, the risk prediction will
be 1.7 %-units higher than what actually will be observed).
Table 1 Characteristics of participants with blood glucose measurement in the Mongolian STEPS 2009 survey. Men and women
aged 35-64 years by diabetes status
Without diabetes (N = 959) Undiagnosed diabetes (N = 59) Total population
Mean / % SD Mean / % SD Difference p Mean / % SD n
Sex, men, % 37.1 59.3 −22.2 0.001 38.4 1018
Age, years 46.3 8.1 47.6 7.7 −1.3 0.222 46.4 8.1 1018
Body weight, kg 68.6 13.2 75.9 14.9 −7.3 <0.001 69.0 13.4 1018
Body height, kg 160.0 7.9 163.1 8.9 −3.1 0.004 160.2 8.0 1018
BMI, kg/m2 26.8 4.7 28.5 4.8 −1.7 0.007 26.9 4.7 1018
Waist circumference, cm 88.8 12.6 95.3 12.2 −6.5 <0.001 89.2 12.7 1018
Systolic blood pressure, mmHg 133.9 23.1 144.1 25.6 −10.2 0.001 134.5 23.3 1018
Diastolic blood pressure, mmHg 85.4 13.6 92.0 13.1 −6.6 <0.001 85.8 13.6 1018
Medication for hypertension, % yes 17.1 30.5 −13.4 0.014 17.9 1018
Hypertension or medication, % yes 44.5 71.2 −26.7 <0.001 46.1 1018
History of elevated glucose, % yes 3.5 10.2 −6.6 0.024 3.9 1018
Leisure time phys. act. daily, % no 60.3 79.7 −19.4 0.003 61.4 1018
Phys. act. at work daily, % no 33.5 35.6 −2.1 0.777 33.6 1018
Sitting time/day, hours 2.9 1.9 4.0 2.8 −1.1 <0.001 2.9 2.0 1018
Sitting time 6h or more/day, % yes 16.0 35.6 −19.6 <0.001 17.1 1018
Fruits weekly, % no 54.8 67.8 −12.9 0.892 55.6 1018
Vegetables weekly, % no 33.2 18.6 14.5 0.351 32.3 1018
Daily smoking, % yes 23.0 33.9 −10.9 0.081 23.7 1018
FINDRISC score (coefficients)a 3.9 6.3 8.0 14.4 −4.1 <0.001 4.1 7.1 1018
FINDRISC score (score points)b 5.8 3.6 7.4 4.0 −1.6 0.001 5.9 3.6 1018
Rotterdam scorec 11.7 5.5 14.7 6.8 −2.9 <0.001 11.9 5.7 1018
aFINDRISC score: based on the original coefficients in the model. Variables included age, BMI, waist circumference, use of antihypertensive medication, history of
high blood glucose, physical activity, and daily consumption of vegetables, fruits or berries
bFINDRISC score: based on the transformed coefficients expressed as score points
cRotterdam score: Variables included age, sex, use of antihypertensive medication and presence of obesity
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Discussion
In this population-based study with a random sample of
the Mongolian adult population, we identified independ-
ent predictors for undiagnosed T2D. In addition to the
well-established risk factors sex, waist circumference,
hypertension, and history of elevated glucose, also leis-
ure time physical activity and total time spent sitting
during daytime hours were identified as independent
predictors for undiagnosed diabetes mellitus. The dis-
crimination between those with and without undiag-
nosed diabetes was improved as compared to the
performance of existing risk scores. Further, the agree-
ment between predicted prevalences and those actually
observed in different categories of predicted risk was
good for both men and women. An internal validation
with bootstrap sampling indicated that the discrimin-
ation and calibration were reasonably good when taking
into account possible overfitting in the model develop-
ment process.
For reporting, a score was chosen rather than regres-
sion coefficients, making it an easy tool for counseling
practice of health practitioners as well as individuals
self-assessment. We identified that most of the established
risk factors for T2D, including sex, waist circumference,
hypertension, history of elevated glucose, and physical
activity, were also independent predictors of undiagnosed
T2D in this population. Physical activity was here defined
specifically as at leisure time, because physical activity at
work was not associated with diabetes. In addition, seden-
tary behavior was strongly associated with diabetes, and
therefore included in the score. In contrast to most other
studies, age was not associated with undiagnosed diabetes.
This is somewhat surprising as the ages in this study cov-
ered a wide range of ages from 35 to 64 years. Further,
BMI did not remain statistically significant predictor in
the multivariate model which included waist circumfer-
ence. This was the case also in the development of the
Chinese risk score [21], even though in European popula-
tions both waist circumference and BMI have been inde-
pendently associated with diabetes [19].
In the model development process applied in this
study, we started with two existing proven risk scores
and evaluated their performance in the Mongolian adult
population. For both risk scores included in the evaluation,
the Finnish FINDRISC score [19] and the Rotterdam study
score [26], the validation of discrimination indicated less
than adequate performance. There are several possible rea-
sons for this. The characteristics of the study populations
Table 2 Logistic regression models on prevalent undiagnosed type 2 diabetes in the Mongolian STEPS 2009 survey. 1018 men and
women aged 35-64 years, of whom 59 had undiagnosed diabetes. Regression coefficients, standard errors (SE) and odds ratios (OR)
with 95 % confidence intervals (CI) are given
Univariate model Multivariate model
β coefficient SE Odds ratio 95 % CI p β coefficient SE Odds ratio 95 % CI p
Sex (men/women) 0.90 0.27 2.47 (1.45–4.22) 0.001 0.74 0.28 2.10 (1.21–3.66) 0.009
Age, years 0.02 0.02 1.02 (0.99–1.05) 0.188 - - - - -
Body weight, kg 0.04 0.01 1.04 (1.02–1.05) 0.000 - - - - -
Height, kg 0.05 0.02 1.05 (1.01–1.09) 0.007 - - - - -
BMI, kg/m2 0.07 0.02 1.07 (1.02–1.12) 0.004 - - - - -
Waist circumference, cm 0.04 0.01 1.04 (1.02–1.06) 0.000 0.02 0.01 1.02 (1.00–1.05) 0.016
Systolic blood pressure, mmHg 0.02 0.00 1.02 (1.01–1.03) 0.001 - - - - -
Diastolic blood pressure, mmHg 0.03 0.01 1.03 (1.02–1.05) 0.000 - - - - -
Medication for hypertension (yes/no) 0.76 0.30 2.13 (1.19–3.80) 0.011 - - - - -
Hypertension or medication (yes/no) 1.12 0.29 3.08 (1.73–5.49) 0.000 0.88 0.32 2.42 (1.30–4.50) 0.005
History of elevated glucose (yes/no) 1.12 0.47 3.08 (1.24–7.66) 0.016 1.14 0.47 3.13 (1.26–7.81) 0.014
Leisure time phys. act. daily (no/yes) 0.95 0.33 2.58 (1.35–4.93) 0.004 0.79 0.34 2.20 (1.14–4.24) 0.019
Phys. act. at work daily (no/yes) 0.09 0.28 1.10 (0.63–1.90) 0.738 - - - - -
Sitting time/day, hours 0.21 0.05 1.23 (1.11–1.37) 0.000 - - - - -
Sitting time 6h or more/day (yes/no) 1.07 0.29 2.91 (1.66–5.10) 0.000 0.82 0.30 2.27 (1.27–4.07) 0.006
Fruits weekly (no/yes) −0.06 0.27 0.94 (0.55–1.59) 0.811 - - - - -
Vegetables weekly (no/yes) −0.50 0.44 0.61 (0.26–1.43) 0.255 - - - - -
Daily smoking (yes/no) 0.54 0.29 1.71 (0.98–3.00) 0.060 - - - - -
Area under ROC curve 76.1
95 % CI (70.1-82.1)
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may differ so that the observed associations might be dif-
ferent, resulting in poor performance. For example, the
mean age of the study population in the Rotterdam study
was 67 years, as compared to 46 years in the present study.
Second, differences in case definitions might lead to differ-
ences in prediction accuracy. In the Finnish study, diabetes
was defined as approval for free-of-charge drug treatment
for diabetes, and in the Rotterdam study, oral glucose tol-
erance test was used for classification of diabetes. Finally,
the Finnish score was originally developed in a prospective
setting [19]. It has since then been validated several times
also in cross-sectional setting, but the performance
has in general always been lower as compared to pro-
spective analyses [39].
Several other diabetes risk scores have been developed,
both in prospective and cross-sectional settings [16–27].
We were not able to evaluate their performance in de-
tail, as most of the existing scores use information re-
garding family history of diabetes, and this information
was not collected in the Mongolian STEP survey.
Additionally, information on behavioral risk factors such
as diet and physical activity were not included in the
most risk scores in Asian settings [21, 28–30]. It is gen-
erally accepted that genetic predisposition is important
for the development of diabetes [40], and the consistency
of information about family history as a factor in several
risk scores support that idea. Therefore, we would propose
a modification to the risk score presented in this paper
with future follow-up surveys.
Several other limitations of this study need to be con-
sidered. First, the sample size was relatively small.
Therefore, we did not attempt to make prediction
models separately for men and women. However, the
calibration analysis indicated that the performance of
the model was accurate in both sexes. Second, we only
had measurements of blood glucose at fasting state. It is
likely that using oral glucose tolerance test we would
have detected more individuals with early disturbances
in glucose metabolism, and this in turn could have re-
sulted in a more sensitive screening tool. Taken together,
Table 3 Final logistic regression model on prevalent undiagnosed type 2 diabetes with corresponding scores in the Mongolian
STEPS 2009 survey. Regression coefficients, odds ratios and 95 % confidence intervals (CI) are given. 1018 men and women aged
35-64 years, of whom 59 had undiagnosed diabetes
β coefficient Odds ratio 95 % CI Score
Intercept −5.223
Sex:
Women (reference) - - 0
Men 0.946 2.58 (1.48–4.49) 4
Waist circumference, cm:
Men <90/ Women <80 (reference) - - 0
Men ≥90/ Women ≥80 0.822 2.28 (1.16–4.46) 3
Hypertension or medication:
No (reference) - - 0
Yes 0.919 2.51 (1.39–4.51) 4
History of elevated glucose:
No (reference) - - 0
Yes 1.108 3.03 (1.17–7.85) 5
Leisure time physical activity daily:
Yes (reference) - - 0
No 0.798 2.22 (1.15–4.28) 3
Sitting time 6h or more/day:
No (reference) - - 0
Yes 0.853 2.35 (1.30–4.25) 3
Score points range 0-22
Area under ROC curve 76.2 76.7
95 % CI (70.2–82.2) (70.9–82.4)
Hypertension or medication: Systolic blood pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg, or on medication for high blood pressure. History of
elevated glucose: healthcare worker informed of an elevated glucose finding in the past
Leisure time physical activity daily: Vigorous- or moderate-intensity sports, fitness or recreational activities which resulted in increases in breathing or heart rate
lasting for at least 10 minutes continuously on at least 5 days per week. Sitting time 6h or more/day: Based on question “How much time do you usually spend
sitting or reclining on a typical day?”
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Table 4 Sensitivity, specificity, positive predictive value, and negative predictive value for selected cut-off values of the modified risk
score in the Mongolian STEPS 2009 survey. 1018 men and women aged 35-64 years, of whom 59 had undiagnosed diabetes
Risk score cut-off point: Proportion of sample, % Sensitivity, % Specificity, % PPV, % NPV, %
≥0 100.0 100.0 0.0 5.8 -
≥ 3 97.2 100.0 2.9 6.0 100.0
≥ 4 82.1 96.6 18.8 6.8 98.9
≥ 5 77.3 96.6 23.9 7.2 99.1
≥ 6 77.1 96.6 24.1 7.3 99.1
≥ 7 63.9 94.9 38.0 8.6 99.2
≥ 8 45.7 83.1 56.6 10.5 98.2
≥ 9 43.4 81.4 58.9 10.9 98.1
≥ 10 41.3 78.0 61.0 11.0 97.8
≥ 11 23.4 57.6 78.7 14.3 96.8
≥ 12 17.1 49.2 84.9 16.7 96.4
≥ 13 16.5 49.2 85.5 17.3 96.5
≥ 14 12.8 39.0 88.8 17.7 95.9
≥ 15 4.0 16.9 96.8 24.4 95.0
≥ 16 3.1 13.6 97.5 25.0 94.8
≥ 17 2.8 11.9 97.7 24.1 94.7
≥ 18 0.7 3.4 99.5 28.6 94.4
Sensitivity: Proportion who fulfill the cut-off criteria among those with undiagnosed diabetes
Specificity: Proportion who do not fulfill the cut-off criteria among those without undiagnosed diabetes
PPV: Positive predictive value: Proportion with undiagnosed diabetes among those who fulfill the cut-off criteria
NPV: Negative predictive value: Proportion without undiagnosed diabetes among those who do not fulfill the cut-off criteria
Cut-off point ≥ 9 most optimal according to the Youden-index
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it is possible that some independent predictors of un-
diagnosed diabetes were not identified with current ana-
lysis; most notably this might be the case for age and
BMI. We are hoping that our results could be further
validated and possibly updated in coming years with
another, independent health survey in Mongolia repre-
senting a larger sample.
Our analysis is conducted in a cross-sectional setting,
aiming to detect persons with already existing, but un-
diagnosed diabetes. For optimal primary prevention,
identification of people even earlier in the disease-course
of diabetes is necessary. With this purpose, the outcome
would have been changed to abnormal glucose so that
those at increased risk of diabetes in the future accord-
ing to their glucose levels can be identified as well. How-
ever, a prospective study with information on incidence
of diabetes would be needed from this specific popula-
tion in order to validate and develop tools to identify
those who are at risk for future onset of diabetes.
Conclusion
In conclusion, it is evident that through local adaptation
and validation of existing European or American-based
diabetes risk tools, sensitivity and potential screening effi-
cacy can be increased. This study demonstrates this
through the development of a simple, low-cost, yet reliable
risk assessment tool for people with undiagnosed
diabetes, developed and validated for the Mongolian
population. The result is a tool that could now be
used for more effective screening within primary
care, in a country and region where diabetes is be-
coming an increasing concern.
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